Clinical Trials and Tribulations in the COVID-19 Era

Advances in treating and preventing Alzheimer disease and other neurocognitive disorders of aging arise from rigorous preclinical and clinical research, with randomized controlled treatment trials as the last and definitive test. The COVID-19 pandemic has greatly disrupted ongoing interventional stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Geriatr Psychiatry
Autors principals: Weinberg, Marc Scott, Patrick, Regan E., Schwab, Nadine A., Owoyemi, Praise, May, Rose, McManus, Alison J., Gerber, Jessica, Harper, David G., Arnold, Steven E., Forester, Brent
Format: Artigo
Idioma:Inglês
Publicat: American Association for Geriatric Psychiatry. Published by Elsevier Inc. 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7236727/
https://ncbi.nlm.nih.gov/pubmed/32507686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2020.05.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars